Author： Hiscox Stephen Morgan Liam Barrow Denise Dutkowski Carol Wakeling Alan Nicholson Robert
Publisher： Springer Publishing Company
ISSN： 0262-0898
Source： Clinical and Experimental Metastasis, Vol.21, Iss.3, 2004-05, pp. : 201-212
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gefitinib ('Iressa', ZD1839): the patients' experience
By Goss G.
EJC Supplements, Vol. 1, Iss. 8, 2003-10 ,pp. :
Access to resources
Recommend
By Bonaccorsi Lorella Marchiani Sara Muratori Monica Forti Gianni Baldi Elisabetta
Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 10, 2004-10 ,pp. :
Clinical benefit in NSCLC: the evidence for gefitinib ('Iressa', ZD1839)
By Lynch T.
EJC Supplements, Vol. 1, Iss. 8, 2003-10 ,pp. :